These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Kidney graft survival and immunologic changes in patients conditioned with donor-specific transfusions prior to transplantation. Bean MA; Mickelson E; Yanagida J; Ishioka S; Hansen JA Transplant Proc; 1988 Dec; 20(6):1084-6. PubMed ID: 2974196 [No Abstract] [Full Text] [Related]
24. Preoperative immunomodulation of renal allograft recipients by concomitant immunosuppression and donor-specific transfusions. Anderson CB; Tyler JD; Rodey GE; Etheredge EE; Anderman CK; Flye MW; Jendrisak MD; Sicard GA Transplant Proc; 1987 Feb; 19(1 Pt 2):1494-7. PubMed ID: 3547868 [TBL] [Abstract][Full Text] [Related]
25. Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome. Kong JM; Jeong JH; Kang JK; Seong IG; Kim BC Transplant Proc; 1995 Feb; 27(1):1036-7. PubMed ID: 7878792 [No Abstract] [Full Text] [Related]
26. Renal allograft recipient immunomodulation by concomitant immunosuppression and donor-specific transfusions. Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA Transplant Proc; 1988 Dec; 20(6):1074-8. PubMed ID: 3059589 [TBL] [Abstract][Full Text] [Related]
28. Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience. El-Husseini AA; Foda MA; Shokeir AA; Shehab El-Din AB; Sobh MA; Ghoneim MA Pediatr Transplant; 2005 Dec; 9(6):763-9. PubMed ID: 16269048 [TBL] [Abstract][Full Text] [Related]
29. Immunosuppression in live-related donor renal transplantation. Iman A; Rao M; Juneja R; Jacob CK Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322 [TBL] [Abstract][Full Text] [Related]
30. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
31. Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation. Alexander JW; Davies CB; First MR; Cofer BR; Munda R; Madden RL; Hariharan S; Schroeder TJ Transplant Proc; 1993 Feb; 25(1 Pt 1):485-7. PubMed ID: 8438389 [No Abstract] [Full Text] [Related]
32. Outcome of donor specific transfusion renal transplants across B cell positive crossmatches. Balakrishnan K; Munda R; First MR; Alexander JW Transplant Proc; 1989 Feb; 21(1 Pt 2):1836. PubMed ID: 2652597 [No Abstract] [Full Text] [Related]
33. Pretreatment with donor-specific blood transfusions in related recipients with high MLC. Salvatierra O; Amend W; Vincenti F; Potter D; Iwaki Y; Opelz G; Terasaki P; Duca R; Hanes D; Cochrum KC; Hopper S; Feduska NJ Transplant Proc; 1981 Mar; 13(1 Pt 1):142-9. PubMed ID: 6455788 [TBL] [Abstract][Full Text] [Related]
34. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Gruessner AC; Sutherland DE Clin Transpl; 2008; ():45-56. PubMed ID: 19708445 [TBL] [Abstract][Full Text] [Related]
35. Pre-transplant blood transfusion and renal allograft outcome: a report of the North American Pediatric Renal Transplant Cooperative Study. Chavers BM; Sullivan EK; Tejani A; Harmon WE Pediatr Transplant; 1997 Aug; 1(1):22-8. PubMed ID: 10084783 [TBL] [Abstract][Full Text] [Related]